Bacil Pharma Limited announced earnings results for the fourth quarter ended March 31, 2021. For the fourth quarter, the company announced total revenue was INR 0.185 million compared to INR 0.183 million a year ago. Net loss was INR 1.938 million compared to INR 0.224 million a year ago. Basic loss per share from continuing operations was INR 0.33 compared to INR 0.04 a year ago. For the full year, total revenue was INR 0.739 million compared to INR 1.428 million a year ago. Net loss was INR 2.392 million compared to INR 3.152 million a year ago. Basic loss per share from continuing operations was INR 0.41 compared to INR 0.54 a year ago.